Birth and infant outcomes assessed in over 5,000 U.S. pregnancies with SARS-CoV-2 infection

This observational study assessed birth and infant outcomes in approximately 5,252 women with laboratory-confirmed SARS-CoV-2 infection reported during pregnancy. The study was conducted across 16 jurisdictions in the United States, with the exposure defined as laboratory-confirmed infection during pregnancy. No comparator group was reported, and the primary outcome was not specified.

No main results, including specific birth or infant outcomes, were reported in the provided data. Secondary outcomes, follow-up duration, and safety data regarding adverse events, serious adverse events, discontinuations, and tolerability were also not reported.

Key limitations of the evidence include the observational design, which cannot establish causality, and the absence of reported results and comparator data. The funding sources and potential conflicts of interest were not disclosed. The practice relevance of these findings cannot be determined until specific outcome data and methodological details are available for review.